Simulations Plus, Inc. $SLP Shares Bought by Charles Schwab Investment Management Inc.

Key Points

• Charles Schwab Investment Management Inc. increased its stake in Simulations Plus, Inc. by 16.2%, currently owning 166,392 shares valued at approximately $4.08 million.
• Simulations Plus reported a positive earnings per share (EPS) of $0.45 for the last quarter, exceeding expectations by $0.19, despite a revenue of $20.36 million falling short of estimates.
• Institutional investors hold 78.08% of Simulations Plus stock, with recent ratings showing a mix of upgrades and downgrades reflecting a general sentiment of "Moderate Buy".

Charles Schwab Investment Management Inc. increased its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 16.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 166,392 shares of the technology company's stock after purchasing an additional 23,139 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.83% of Simulations Plus worth $4,080,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Fifth Third Bancorp raised its position in Simulations Plus by 33.8% during the 1st quarter. Fifth Third Bancorp now owns 1,485 shares of the technology company's stock worth $36,000 after buying an additional 375 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in shares of Simulations Plus by 42.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock worth $72,000 after acquiring an additional 764 shares during the period. US Bancorp DE raised its holdings in Simulations Plus by 15.6% during the first quarter. US Bancorp DE now owns 6,576 shares of the technology company's stock worth $161,000 after purchasing an additional 889 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Simulations Plus in the first quarter valued at about $210,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Simulations Plus by 4.4% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,103 shares of the technology company's stock valued at $254,000 after purchasing an additional 380 shares in the last quarter. 78.08% of the stock is currently owned by hedge funds and other institutional investors.

Simulations Plus Trading Up 0.2%

Shares of NASDAQ:SLP traded up $0.03 during midday trading on Tuesday, hitting $14.20. 91,378 shares of the stock were exchanged, compared to its average volume of 429,473. Simulations Plus, Inc. has a twelve month low of $12.39 and a twelve month high of $37.67. The company has a 50 day moving average price of $14.78 and a 200-day moving average price of $23.76. The stock has a market cap of $285.87 million, a P/E ratio of -4.51 and a beta of 0.85.

Simulations Plus (NASDAQ:SLP - Get Free Report) last issued its quarterly earnings data on Monday, July 14th. The technology company reported $0.45 EPS for the quarter, beating analysts' consensus estimates of $0.26 by $0.19. Simulations Plus had a negative net margin of 78.63% and a positive return on equity of 11.62%. The firm had revenue of $20.36 million for the quarter, compared to analysts' expectations of $22.83 million. During the same period in the prior year, the company earned $0.27 EPS. The firm's revenue was up 9.8% on a year-over-year basis. On average, equities research analysts expect that Simulations Plus, Inc. will post 1.09 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. KeyCorp downgraded Simulations Plus from an "overweight" rating to a "sector weight" rating in a research note on Tuesday, July 15th. Craig Hallum cut their price objective on Simulations Plus from $45.00 to $36.00 and set a "buy" rating for the company in a research report on Friday, June 13th. William Blair reissued an "outperform" rating on shares of Simulations Plus in a report on Tuesday, July 15th. Zacks Research upgraded shares of Simulations Plus to a "hold" rating in a research report on Tuesday, August 12th. Finally, Stephens cut their price target on shares of Simulations Plus from $28.00 to $20.00 and set an "overweight" rating for the company in a report on Tuesday, July 15th. Four equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $26.50.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.